Gambaran Demografi COVID-19 di Kabupaten Cirebon

The Demographic Factor of COVID-19 in Cirebon

  • Dea Triasari Indriyanti Wahidin Fakultas Kesehatan Masyarakat, Universitas Indonesia
  • Sudarto Ronoatmodjo Fakultas Kesehatan Masyarakat,Universitas Indonesia
DOI: https://doi.org/10.56338/mppki.v7i1.4625
Keywords: COVID-19, Jenis Kelamin, Usia, Kabupaten Cirebon

Abstract

Latar belakang: Sebuah penyakit infeksi yang disebabkan oleh virus SARS CoV2 ditetapkan sebagai pandemi pada 11 Maret 2020 setelah menginfeksi 118.000 orang di 114 negara hanya dalam waktu 3 bulan. Penyakit ini menyerang semua lapisan masyarakat sehingga menjadi tantangan global yang sulit dikendalikan.

Tujuan: Berdasarkan hal tersebut peneliti tertarik untuk melihat gambaran demografi berdasarkan usia dan jenis kelamin di Kabupaten Cirebon dimana Kabupaten Cirebon adalah Kabupaten perbatasan Jawa Barat dan Jawa Tengah

Metode: Desain penelitian ini adalah observasional analitik potong lintang dengan sampel sebanyak 36.700 yang diambil dari laboratorium COVID-19 FK UGJ dalam rentang Januari 2022 - Juni 2022.

Hasil: Hasil penelitian menunjukan bahwa penderita COVID-19 mayoritas adalah perempuan (56,7%) prevalensi usia tertinggi adalah pada kelompok usia 26-35 tahun (23,7%).

Kesimpulan: Berdasarkan kesimpulan tersebut maka disarankan kepada Dinas Kesehatan Kota dan Kabupaten Cirebon agar lebih meningkatkan lagi kegiatan promosi kesehatan dan mengajak masyarakat agar berperan aktif dalam upaya pencegahan penularan COVID-19.  

 

References

WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. WHO Director General’s speeches. 2020 [cited 2022 May 6]. p. 4. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med [Internet]. 2020 Feb 20 [cited 2023 May 13];382(8):727–33. Available from: https://www.nejm.org/doi/10.1056/NEJMoa2001017

Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020 54 [Internet]. 2020 Mar 2 [cited 2022 Jun 19];5(4):536–44. Available from: https://www.nature.com/articles/s41564-020-0695-z

CDC. SARS-CoV-2 Variant Classifications and Definitions [Internet]. Cdc. 2021 [cited 2022 Jun 3]. p. 1–12. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html

World Health Organization (WHO). Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern [Internet]. 2021 [cited 2023 May 14]. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

Mahase E. Covid-19: What do we know about omicron sublineages? BMJ [Internet]. 2022 Feb 11 [cited 2023 Dec 11];376. Available from: https://pubmed.ncbi.nlm.nih.gov/35149516/

Direktorat Surveilans dan Karantina Kesehatanm KR. Bagaimana Tingkat Keparahan Penyakit Saat Terinfeksi COVID-19 Varian Omicron? [Internet]. [cited 2023 Jul 8]. Available from: https://faq.kemkes.go.id/faq/bagaimana-tingkat-keparahan-penyakit-saat-terinfeksi-covid-19-varian-omicron

Direktorat Surveilans dan Karantina Kesehatan KR. Apakah Vaksinasi yang Sudah Dilakukan Efektif Cegah Penularan COVID-19 Varian Omicron? [Internet]. [cited 2023 Jul 8]. Available from: https://faq.kemkes.go.id/faq/apakah-vaksinasi-yang-sudah-dilakukan-efektif-cegah-penularan-covid-19-varian-omicron

Widyawati. Antisipasi Gelombang Ketiga, Kenali Ciri dan Cara Mencegah Penularan Omicron – Sehat Negeriku [Internet]. KEMENKES. 2022 [cited 2023 Jul 8]. Available from: https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220127/0839222/antisipasi-gelombang-ketiga-kenali-ciri-dan-cara-mencegah-penularan-omicron/

Surveilans COVID-19 Kabupaten Cirebon. Evaluasi Penanganan Kasus COVID-19 Kabupaten Cirebon. Cirebon; 2022.

Cortis D. On Determining the Age Distribution of COVID-19 Pandemic. Front Public Heal. 2020 May 15;8:548691.

Davies NG, Klepac P, Liu Y, Prem K, Jit M, Pearson CAB, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med [Internet]. 2020 Jun 16 [cited 2023 Dec 10];26(8):1205–11. Available from: https://www.nature.com/articles/s41591-020-0962-9

Pennington AF, Kompaniyets L, Summers AD, Danielson ML, Goodman AB, Chevinsky JR, et al. Risk of Clinical Severity by Age and Race/Ethnicity among Adults Hospitalized for COVID-19 - United States, March-September 2020. Open Forum Infect Dis. 2021 Feb 1;8(2).

Czeisler MÉ, Tynan MA, Howard ME, Honeycutt S, Fulmer EB, Daniel ;, et al. MMWR - Public Attitudes, Behaviors, and Beliefs Related to COVID-19, Stay-at-Home Orders, Nonessential Business Closures, and Public Health Guidance — United States, New York City, and Los Angeles, May 5–12, 2020. [cited 2023 Dec 11]; Available from: https://www.hrsa.gov/rural-health/about-us/

Furuse Y, Sando E, Tsuchiya N, Miyahara R, Yasuda I, K.Ko Y, et al. Clusters of Coronavirus Disease in Communities, Japan, January–April 2020. Emerg Infect Dis [Internet]. 2020 Sep 1 [cited 2023 Dec 11];26(9):2176. Available from: /pmc/articles/PMC7454082/

Boehmer TK, Devies J, Caruso E, Van Santen KL, Tang S, Black CL, et al. Morbidity and Mortality Weekly Report Changing Age Distribution of the COVID-19 Pandemic-United States, May-August 2020. [cited 2023 Dec 11]; Available from: https://www.cdc.gov/covid-data-tracker/index.html#trends.

Wu C, Qian Y. The gender peak effect: Women are most vulnerable to infections during COVID-19 peaks. Front Public Heal [Internet]. 2022 Aug 9 [cited 2023 Dec 10];10. Available from: /pmc/articles/PMC9395988/

Kabeer N, Razavi S, van der Meulen Rodgers Y. Feminist Economic Perspectives on the COVID-19 Pandemic. Fem Econ [Internet]. 2021 Apr 3 [cited 2023 Dec 12];27(1–2):1–29. Available from: https://www.tandfonline.com/doi/abs/10.1080/13545701.2021.1876906

Doerre Id A, Doblhammer G. The influence of gender on COVID-19 infections and mortality in Germany: Insights from age- and gender-specific modeling of contact rates, infections, and deaths in the early phase of the pandemic. 2022; Available from: https://doi.org/10.1371/journal.pone.0268119.g001

Sobotka T, Brzozowska Z, Muttarak R, Zeman K, Lego V di. Age, gender and COVID-19 infections. medRxiv [Internet]. 2020 May 26 [cited 2023 Dec 12];2020.05.24.20111765. Available from: https://www.medrxiv.org/content/10.1101/2020.05.24.20111765v1

Published
2024-01-05
How to Cite
Wahidin, D. T. I., & Sudarto Ronoatmodjo. (2024). Gambaran Demografi COVID-19 di Kabupaten Cirebon: The Demographic Factor of COVID-19 in Cirebon. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 7(1), 251-256. https://doi.org/10.56338/mppki.v7i1.4625
Issue
Vol. 7 No. 1: JANUARY 2024 - Media Publikasi Promosi Kesehatan Indonesia (MPPKI)
Section
Research Article

Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:

  1. Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.

  2. Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.

  3. License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.